IMMUNOME INC (IMNM) — insider trading
Health Care · NASDAQ
IMMUNOME INC (IMNM) has 26 reported SEC Form 4 insider transactions in our data, including 12 open-market sales among the most recent 26 (latest 2026-07-07).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-07 | Horn Kinney | Officer (CHIEF BUSINESS OFFICER) | Option exercise / conversion (derivative) | 1,092 | $0.00 | $0 | Form 4 |
| 2026-07-07 | Horn Kinney | Officer (CHIEF BUSINESS OFFICER) | Open-market sale | 1,092 | $25.00 | $27.3K | Form 4 |
| 2026-07-07 | Horn Kinney | Officer (CHIEF BUSINESS OFFICER) | Option exercise / conversion | 1,092 | $12.92 | $14.1K | Form 4 |
| 2026-07-07 | Barchas Isaac | Director | Open-market sale | 16,906 | $24.20 | $409.1K | Form 4 |
| 2026-07-06 | Barchas Isaac | Director | Open-market sale | 83,094 | $24.11 | $2.00M | Form 4 |
| 2026-07-02 | Lechleider Robert | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 55,000 | $0.00 | $0 | Form 4 |
| 2026-07-02 | Lechleider Robert | Officer (Chief Medical Officer) | Open-market sale | 16,072 | $23.44 | $376.7K | Form 4 |
| 2026-07-02 | Lechleider Robert | Officer (Chief Medical Officer) | Open-market sale | 16,214 | $22.76 | $369.0K | Form 4 |
| 2026-07-02 | Lechleider Robert | Officer (Chief Medical Officer) | Open-market sale | 22,714 | $21.95 | $498.6K | Form 4 |
| 2026-07-02 | Lechleider Robert | Officer (Chief Medical Officer) | Option exercise / conversion | 55,000 | $8.73 | $480.1K | Form 4 |
| 2026-07-02 | Barchas Isaac | Director | Open-market sale | 24,335 | $23.33 | $567.7K | Form 4 |
| 2026-07-02 | Barchas Isaac | Director | Open-market sale | 75,665 | $22.35 | $1.69M | Form 4 |
| 2026-06-30 | Barchas Isaac | Director | Open-market sale | 101,050 | $21.12 | $2.13M | Form 4 |
| 2026-06-25 | Lechleider Robert | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 55,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Lechleider Robert | Officer (Chief Medical Officer) | Open-market sale | 14,420 | $20.66 | $297.9K | Form 4 |
| 2026-06-25 | Lechleider Robert | Officer (Chief Medical Officer) | Open-market sale | 40,580 | $19.56 | $793.7K | Form 4 |
| 2026-06-25 | Lechleider Robert | Officer (Chief Medical Officer) | Option exercise / conversion | 55,000 | $8.73 | $480.1K | Form 4 |
| 2026-06-15 | Rosett Max | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 60,000 | $0.00 | $0 | Form 4 |
| 2026-06-15 | Rosett Max | Officer (Chief Financial Officer) | Open-market sale | 60,000 | $18.23 | $1.09M | Form 4 |
| 2026-06-15 | Rosett Max | Officer (Chief Financial Officer) | Option exercise / conversion | 60,000 | $1.05 | $63.0K | Form 4 |
| 2026-06-10 | SCHAFER CAROL | Director | Grant / award / vesting (derivative) | 9,897 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Barchas Isaac | Director | Grant / award / vesting (derivative) | 9,897 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Boylan James P | Director | Grant / award / vesting (derivative) | 9,897 | $0.00 | $0 | Form 4 |
| 2026-06-10 | BIENAIME JEAN JACQUES | Director | Grant / award / vesting (derivative) | 9,897 | $0.00 | $0 | Form 4 |
| 2026-06-10 | WAGENHEIM PHILIP | Director | Grant / award / vesting (derivative) | 9,897 | $0.00 | $0 | Form 4 |
| 2026-06-10 | SWAIN SANDRA M | Director | Grant / award / vesting (derivative) | 9,897 | $0.00 | $0 | Form 4 |
Ask the chat about IMNM's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: IMMUNOME INC (IMNM).
Last updated 2026-07-07 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.